Immix Biopharma, Inc.
IMMX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,586 | -$6,623 | -$4,543 | -$4,812 |
| Dep. & Amort. | $135 | $80 | $59 | $41 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $470 | $532 | $868 | $0 |
| Change in WC | $1,075 | $701 | $1,930 | $2,589 |
| Other Non-Cash | $0 | $0 | $0 | $706 |
| Operating Cash Flow | -$5,906 | -$5,310 | -$1,685 | -$1,476 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$372 | -$128 | -$68 | -$507 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$372 | -$128 | -$68 | -$507 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10,774 | $1,104 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$166 | $6 | $0 | $0 |
| Financing Cash Flow | $10,608 | $1,110 | $0 | $0 |
| Forex Effect | -$21 | $44 | -$8 | -$25 |
| Net Chg. in Cash | $4,309 | -$4,283 | -$1,761 | -$2,008 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,638 | $15,921 | $17,682 | $19,690 |
| End Cash | $15,947 | $11,638 | $15,921 | $17,682 |
| Free Cash Flow | -$6,278 | -$5,437 | -$1,753 | -$1,983 |